+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cytomegalovirus Tests Market by Product (Antigen Detection Test, Nucleic Acid Amplification Test, Serological Assay), Test Type (Qualitative, Quantitative), Application, End User, Sample Type - Global Forecast 2025-2030- Product Image
Cytomegalovirus Tests Market by Product (Antigen Detection Test, Nucleic Acid Amplification Test, Serological Assay), Test Type (Qualitative, Quantitative), Application, End User, Sample Type - Global Forecast 2025-2030- Product Image
Sale

Cytomegalovirus Tests Market by Product (Antigen Detection Test, Nucleic Acid Amplification Test, Serological Assay), Test Type (Qualitative, Quantitative), Application, End User, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968363
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cytomegalovirus Tests Market is rapidly evolving, presenting new growth opportunities as healthcare organizations respond to shifting diagnostic needs, regulatory changes, and emerging clinical challenges

. Effective diagnostics are central to disease management, guiding both public health strategies and organizational investments in innovation.

Market Snapshot: Cytomegalovirus Tests Market Size and Growth

The Cytomegalovirus Tests Market grew from USD 680.78 million in 2024 to USD 731.24 million in 2025. It is expected to continue growing at a CAGR of 7.07%, reaching USD 1.02 billion by 2030. This robust upward trend is driven by increased demand in immunocompromised populations, advances in molecular diagnostics, and expanding applications in both developed and emerging markets. Diagnostic transformation is underpinned by technology integration, supply chain adaptations, and regional healthcare investment.

Scope & Segmentation: Comprehensive Analysis Across Segments, Regions, and Technologies

  • Product Types: Includes antigen detection tests (immunofluorescence assay, lateral flow assay), nucleic acid amplification tests (digital polymerase chain reaction, isothermal amplification, real-time polymerase chain reaction), and serological assays (chemiluminescent immunoassay, enzyme linked immunosorbent assay, lateral flow immunoassay).
  • Test Types: Encompasses qualitative and quantitative diagnostics.
  • Applications: Covers diagnostic testing, donor screening, prenatal testing, and broad-based screening initiatives.
  • End Users: Targets clinics, diagnostic laboratories, hospitals, and research institutes requiring precise, throughput-optimized instrumentation.
  • Sample Types: Utilizes saliva, tissue, urine, and whole blood to support diverse clinical workflows.
  • Regional Coverage: Explores the Americas (including the United States and key states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major countries across these regions), and Asia-Pacific (with focus countries such as China, India, Japan, Australia, and others).
  • Key Companies Reviewed: Evaluates offerings from F. Hoffmann-La Roche Ltd, Abbott Laboratories, Qiagen N.V., bioMérieux SA, Hologic, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, and PerkinElmer, Inc.

Cytomegalovirus Tests Market: Key Takeaways for Senior Decision-Makers

  • Advanced molecular and immunoassay diagnostics continue to drive the transition toward earlier, more accurate detection, improving patient management and outcomes.
  • Adoption of point-of-care platforms, such as lateral flow and isothermal amplification assays, is broadening access to vital diagnostics in decentralized or resource-limited settings.
  • Regional variations highlight the strategic importance of aligning product portfolios with local reimbursement, infrastructure, and regulatory landscapes to accelerate market entry and penetration.
  • Supplier partnerships and vertical integration are increasingly vital as organizations seek to mitigate supply chain disruptions, especially amid changes in global trade and regulatory environments.
  • Continued innovation in digital PCR and immunoassay automation is supporting high-throughput laboratories facing rising demands in donor screening and prenatal testing.
  • Competitiveness is being shaped by acquisitions, technology collaborations, and robust product pipelines focused on modularity and adaptability to evolving clinical needs.

Tariff Impact: Responding to U.S. Policy Shifts in 2025

Forthcoming adjustments to United States tariffs are expected to affect the cost structure and supply chain resilience within the cytomegalovirus diagnostics market. Increased duties on imported reagents and components may prompt laboratories and manufacturers to reconsider sourcing strategies, negotiate new contracts, and explore domestic supplier partnerships. Some companies are already moving to localize production or diversify supplier networks, though such shifts require capital investment and careful navigation of regulatory approvals. The net impact may influence time-to-market for new assay formats and the accessibility of diagnostics for end users.

Methodology & Data Sources

This report applies a multi-pronged research framework, integrating primary qualitative interviews with laboratory leaders and clinical experts, comprehensive secondary data review from regulatory and trade sources, and robust market triangulation. An industry advisory panel validated findings to ensure depth, relevance, and accuracy in trend identification and strategic recommendations.

Why This Report Matters for Strategic Planning and Investment

  • Delivers actionable intelligence for optimizing R&D, procurement, and go-to-market strategies amid ongoing supply, regulatory, and technological changes.
  • Enables informed decision-making on portfolio diversification, regional expansion, and technology partnerships to sustain competitive positioning.
  • Clarifies the dynamic landscape of cytomegalovirus diagnostics, highlighting factors that influence adoption, stakeholder priorities, and evolving clinical needs.

Conclusion

The cytomegalovirus testing market’s evolution is defined by innovation, regional adaptation, and regulatory responsiveness. This report equips leaders to identify strategic opportunities, safeguard supply chain continuity, and strengthen clinical impact in a rapidly shifting landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of multiplex PCR assays enabling simultaneous detection of multiple viral pathogens including CMV
5.2. Rising demand for rapid point of care CMV diagnostics to facilitate timely management in neonatal care settings
5.3. Integration of next generation sequencing techniques to provide comprehensive CMV genome analysis for drug resistance monitoring
5.4. Emerging FDA clearances of highly sensitive immunoassays for early detection of congenital cytomegalovirus infections in infants
5.5. Growing implementation of newborn screening programs for congenital CMV in North America and Europe driving test volumes
5.6. Cost pressure leading to development of automated high throughput CMV testing platforms in reference laboratories worldwide
5.7. Strategic collaborations between diagnostic companies and healthcare providers to expand CMV screening in transplant patients
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cytomegalovirus Tests Market, by Product
8.1. Introduction
8.2. Antigen Detection Test
8.2.1. Immunofluorescence Assay
8.2.2. Lateral Flow Assay
8.3. Nucleic Acid Amplification Test
8.3.1. Digital Polymerase Chain Reaction
8.3.2. Isothermal Amplification
8.3.3. Real Time Polymerase Chain Reaction
8.4. Serological Assay
8.4.1. Chemiluminescent Immunoassay
8.4.2. Enzyme Linked Immunosorbent Assay
8.4.3. Lateral Flow Immunoassay
9. Cytomegalovirus Tests Market, by Test Type
9.1. Introduction
9.2. Qualitative
9.3. Quantitative
10. Cytomegalovirus Tests Market, by Application
10.1. Introduction
10.2. Diagnostic
10.3. Donor Screening
10.4. Prenatal Testing
10.5. Screening
11. Cytomegalovirus Tests Market, by End User
11.1. Introduction
11.2. Clinic
11.3. Diagnostic Laboratory
11.4. Hospital
11.5. Research Institute
12. Cytomegalovirus Tests Market, by Sample Type
12.1. Introduction
12.2. Saliva
12.3. Tissue
12.4. Urine
12.5. Whole Blood
13. Americas Cytomegalovirus Tests Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cytomegalovirus Tests Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cytomegalovirus Tests Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Qiagen N.V.
16.3.4. bioMérieux SA
16.3.5. Hologic, Inc.
16.3.6. Siemens Healthineers AG
16.3.7. Thermo Fisher Scientific Inc.
16.3.8. Danaher Corporation
16.3.9. Becton, Dickinson and Company
16.3.10. PerkinElmer, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CYTOMEGALOVIRUS TESTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CYTOMEGALOVIRUS TESTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CYTOMEGALOVIRUS TESTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CYTOMEGALOVIRUS TESTS MARKET: RESEARCHAI
FIGURE 26. CYTOMEGALOVIRUS TESTS MARKET: RESEARCHSTATISTICS
FIGURE 27. CYTOMEGALOVIRUS TESTS MARKET: RESEARCHCONTACTS
FIGURE 28. CYTOMEGALOVIRUS TESTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CYTOMEGALOVIRUS TESTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUALITATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUALITATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUANTITATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUANTITATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DONOR SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DONOR SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 112. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 113. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 114. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 115. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 116. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 117. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 118. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 119. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 120. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 121. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 128. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 129. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 130. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 133. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 134. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 135. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 210. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 211. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 212. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 213. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 214. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 215. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 216. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 217. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 225. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 226. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 227. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 228. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 229. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 230. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 231. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 232. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 233. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 240. FRANCE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 257. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 258. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 259. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 260. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 261. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 262. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 263. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 264. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 265. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 266. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 267. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 272. ITALY CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 273. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 274. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 275. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 276. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 277. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 278. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 279. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 280. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 281. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 282. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 283. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 288. SPAIN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA CY

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Cytomegalovirus Tests market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Qiagen N.V.
  • bioMérieux SA
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 731.24 Million
Forecasted Market Value ( USD ) by 2030 $ 1020 Million
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

2024-2029 Global CMV Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities - Product Image

2024-2029 Global CMV Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • Report
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From
2024-2028 Global Cytomegalovirus (CMV) Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Cytomegalovirus (CMV) Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
Cytomegalovirus (CMV) Tests Market Size By Segments, Share, Regulatory, Reimbursement, And Forecast To 2036 - Product Image

Cytomegalovirus (CMV) Tests Market Size By Segments, Share, Regulatory, Reimbursement, And Forecast To 2036

  • Report
  • 52 Pages
  • Global
From
Cytomegalovirus Treatment Market by Treatment Type (Curative, Prophylaxis), Route Of Administration (Intravenous, Oral, Topical), End User, Distribution Channel, Patient Type - Global Forecast 2025-2030 - Product Image

Cytomegalovirus Treatment Market by Treatment Type (Curative, Prophylaxis), Route Of Administration (Intravenous, Oral, Topical), End User, Distribution Channel, Patient Type - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Cytomegalovirus Treatment Drugs Market by Drug Type (Nucleoside Analogues, Terminase Inhibitors), Route Of Administration (Intravenous, Oral), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Cytomegalovirus Treatment Drugs Market by Drug Type (Nucleoside Analogues, Terminase Inhibitors), Route Of Administration (Intravenous, Oral), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From

About the Cytomegalovirus Test Market

The Cytomegalovirus Test is a type of infectious disease test used to detect the presence of the cytomegalovirus (CMV) in a patient's body. CMV is a common virus that can cause serious health problems in people with weakened immune systems. The test is used to diagnose CMV infection, monitor the progression of the infection, and determine the effectiveness of treatment. It is also used to screen pregnant women for CMV infection, as it can cause birth defects if the mother is infected. The Cytomegalovirus Test market is composed of a variety of diagnostic companies that offer tests for CMV. These companies provide a range of products, including ELISA kits, PCR kits, and rapid tests. Some of the companies in the market include Abbott, Bio-Rad, Roche, Siemens, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.